IL6 and Hepatic fibrosis: These results collectively indicate that hydroxyasiaticoside noticeably inhibits the expression levels of TNF-α and IL-6, and simultaneously improves schistosomiasis-induced liver fibrosis by regulating inflammatory response factors in vivo.